STOCK TITAN

Roadzen (RDZN) prices $8M registered direct stock sale

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Roadzen Inc. entered into a registered direct equity offering, selling 4,705,870 ordinary shares at $1.70 per share to institutional investors. The transaction, conducted on a best efforts basis through Maxim Group LLC, generated gross proceeds of about $7,999,979 before fees and expenses.

The shares were issued under Roadzen’s effective Form S-3 shelf registration, with closing on or about May 5, 2026. Roadzen plans to use the net proceeds for working capital and general corporate purposes and may also apply a portion toward repayment of outstanding indebtedness. For 20 days from May 5, 2026, the company agreed to limit additional equity issuances and certain registration filings, subject to specified exceptions.

Positive

  • None.

Negative

  • None.
Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Shares sold 4,705,870 shares Ordinary shares issued in registered direct offering
Offering price $1.70 per share Price for ordinary shares sold to institutional investors
Gross proceeds $7,999,979 Total before placement fees and expenses
Estimated gross proceeds Approximately $8.0 million Rounded gross proceeds disclosed in press release
Placement fee rate 6.0% Cash fee on aggregate gross proceeds to Maxim Group LLC
Accountable expenses $30,000 Reimbursement of placement agent’s accountable expenses
Lock-up period 20 days Restrictions on additional issuances from May 5, 2026
Shelf registration file number 333-282966 Form S-3 shelf used for this offering
registered direct offering financial
"ordinary shares at an offering price of $1.70 per share, in a registered direct offering"
A registered direct offering is a way for a company to sell new shares of its stock directly to select investors with regulatory approval. This method allows the company to raise funds quickly and efficiently without needing a public auction, similar to offering exclusive access to a limited number of buyers. For investors, it often provides an opportunity to purchase shares at a favorable price, while giving the company immediate access to capital.
shelf registration statement on Form S-3 regulatory
"pursuant to a shelf registration statement on Form S-3 (File No. 333-282966)"
A shelf registration statement on Form S-3 is a pre-approved filing with the Securities and Exchange Commission that lets an eligible public company register securities in advance and sell them later in one or more offerings without repeating the full registration process. Think of it like a pre-approved funding line: it gives management the flexibility to raise capital quickly when market conditions are right, a move that can affect share supply, dilution and investor returns, so investors monitor it as a signal of potential financing activity.
placement agency agreement financial
"entered into a placement agency agreement (the “Agency Agreement”) with Maxim Group LLC"
best efforts offering financial
"for the purchase and sale, in a best efforts offering (the “Offering”)"
forward-looking statements regulatory
"This press release includes forward-looking statements within the meaning of Section 27A"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
false 0001868640 0001868640 2026-05-04 2026-05-04 0001868640 RDZN:OrdinarySharesParValue0.0001PerShareMember 2026-05-04 2026-05-04 0001868640 RDZN:WarrantsEachWarrantExercisableForOneOrdinaryShareEachAtExercisePriceOf11.50PerShareMember 2026-05-04 2026-05-04 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 4, 2026

 

 

 

ROADZEN INC.

(Exact name of Registrant as Specified in Its Charter)

 

 

 

British Virgin Islands   001-41094   98-1600102
(State or Other Jurisdiction
of Incorporation)
 

(Commission

File Number)

  (IRS Employer
Identification No.)

 

111 Anza Blvd

Suite 109

       
Burlingame, California       94010
(Address of Principal Executive Offices)       (Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (347) 745-6448

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Ordinary Shares, par value $0.0001 per share   RDZN   The Nasdaq Stock Market LLC
Warrants, each warrant exercisable for one ordinary share, each at an exercise price of $11.50 per share   RDZNW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 1.01 Entry into a Material Definitive Agreement.

 

On May 4, 2026, Roadzen Inc. (the “Company”) entered into a placement agency agreement (the “Agency Agreement”) with Maxim Group LLC (the “Placement Agent”) and a securities purchase agreement (the “Purchase Agreement”) with purchasers for the purchase and sale, in a best efforts offering (the “Offering”), of 4,705,870 of the Company’s ordinary shares, par value $0.0001 per share (“Ordinary Shares”), at an offering price of $1.70 per Share.

 

The Offering closed on May 5, 2026. The Company received gross proceeds of $7,999,979 in connection with the Offering, before deducting Placement Agent fees and other Offering expenses payable by the Company. The Company intends to use the net proceeds from the Offering for working capital and general corporate purposes. The Company may also use a portion of the net proceeds to repay indebtedness outstanding.

 

The 4,705,870 Ordinary Shares sold in the Offering were offered and sold pursuant to the Company’s registration statement on Form S-3 (File No. 333-282966), previously filed with the Securities and Exchange Commission (the “SEC”) on November 1, 2024 and declared effective on November 12, 2024, including the base prospectus contained therein and a prospectus supplement dated May 4, 2026.

 

As part of its compensation for acting as Placement Agent for the Offering, the Company paid the Placement Agent a cash fee of 6.0% of the aggregate gross proceeds and $30,000 as reimbursement of the Placement Agent’s accountable expenses.

 

The Agency Agreement and the Purchase Agreement contain customary representations, warranties and covenants made by the Company. They also provide for customary indemnification by the Company for losses or damages arising out of or in connection with the Offering, among other things. In addition, pursuant to the terms of the Agency Agreement, the Company has agreed for a period of 20-days from May 5, 2026, subject to certain exceptions, not to (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any Ordinary Shares or Ordinary Share equivalents, other than certain exempted issuance, or (ii) file any registration statement or any amendment or supplement thereto, other than the prospectus supplement in connection with the Offering or a registration statement on Form S-8 in connection with any employee benefit plan.

 

The foregoing descriptions of the Agency Agreement and the Purchase Agreement do not purport to be complete and are qualified in their entirety by reference to the copies of the Agency Agreement and the Purchase Agreement, which are filed herewith as Exhibits 10.1 and 10.2, respectively.

 

The representations, warranties and covenants contained in the Agency Agreement and the Purchase Agreement were made only for purposes of such agreement and as of specific dates, were solely for the benefit of the parties to the applicable agreement and may be subject to limitations agreed upon by the contracting parties. Accordingly, each of the Agency Agreement and the Purchase Agreement is incorporated herein by reference only to provide investors with information regarding the terms of such agreement, and not to provide investors with any other factual information regarding the Company or its business, and should be read in conjunction with the disclosures in the Company’s periodic reports and other filings with the SEC.

 

The legal opinion, including the related consent, of Maples & Calder relating to the issuance and sale of the Ordinary Shares issued in the Offering is filed as Exhibit 5.1 hereto.

 

Item 8.01 Other Events.

 

On May 4, 2026, the Company issued a press release announcing the pricing of the Offering. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit Number   Description of Exhibit
     
5.1   Opinion of Maples & Calder.
10.1   Placement Agency Agreement, dated May 4, 2026.
10.2   Form of Securities Purchase Agreement, dated May 4, 2026.
23.1   Consent of Maples & Calder (included in Exhibit 5.1).
99.1   Press Release dated May 4, 2026.
104   Cover page interactive data file (embedded within the Inline XBRL document).

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    ROADZEN INC.
       
Date: May 5, 2026 By: /s/ Jean-Noel Gallardo
    Name: Jean-Noel Gallardo
    Title: Chief Financial Officer

 

 

 

 

Exhibit 99.1

 

Roadzen Announces Pricing of $8.0 Million Registered Direct Offering of Ordinary Shares

 

NEW YORK, May 4, 2026 (GLOBE NEWSWIRE) — Roadzen Inc. (Nasdaq: RDZN) (“Roadzen” or the “Company”), a global leader in AI at the convergence of insurance and mobility, today announced that it has entered into a securities purchase agreement with institutional investors for the purchase and sale of 4,705,870 ordinary shares at an offering price of $1.70 per share, in a registered direct offering (the “Offering”).

 

The gross proceeds to the Company from the Offering are estimated to be approximately $8.0 million before deducting the placement agent’s fees and other estimated offering expenses. The offering is expected to close on or about May 5, 2026, subject to the satisfaction of customary closing conditions.

 

Maxim Group LLC is acting as the sole placement agent in connection with the Offering.

 

The securities are being offered pursuant to a shelf registration statement on Form S-3 (File No. 333-282966), which was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on November 12, 2024. The offering will be made only by means of a prospectus supplement and the accompanying prospectus that form a part of such registration statement. A prospectus supplement relating to the Offering will be filed by the Company with the SEC. When available, copies of the prospectus supplement and accompanying prospectus can be obtained at the SEC’s website at www.sec.gov or from Maxim Group LLC, 300 Park Avenue, New York, NY 10022, Attention: Syndicate Department, via email at syndicate@maximgrp.com, or telephone at (212) 895-3500.

 

This press release does not constitute an offer to sell or the solicitation of an offer to buy, nor will there be any sales of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.

 

About Roadzen Inc.

 

Roadzen Inc. (Nasdaq: RDZN) is a global leader in AI at the convergence of insurance and mobility. Roadzen builds technology that helps insurers, automakers, and fleets better predict and prevent risk, automate claims, and deliver seamless, embedded insurance experiences.

 

Thousands of clients across North America, Europe, and Asia — from the world’s leading insurers, carmakers, and fleets to dealerships and agents — use Roadzen’s technology to build new products, sell insurance, process claims, and improve road safety. Roadzen’s pioneering work in telematics, generative AI, and computer vision has earned recognition from Forbes, Fortune, and Financial Express as one of the world’s top AI innovators.

 

Headquartered in Burlingame, California, Roadzen employs more than 300 people across offices in the U.S., U.K., and India. Learn more at www.roadzen.ai

 

 
 

 

Cautionary Statement Regarding Forward Looking Statements

 

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” and “continue,” or the negative of such terms or other similar expressions. Such statements include, but are not limited to, statements regarding our anticipated future financial results (including ability to achieve breakeven Adjusted EBITDA), the anticipated closing of our registered direct offering, the anticipated benefits of our products and solutions, strategy, demand for our products, expansion plans, future operations, future operating results, estimated revenues, losses, projected costs, prospects, plans and objectives of management, as well as all other statements other than statements of historical fact included in this press release. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in “Risk Factors” in our Securities and Exchange Commission (“SEC”) filings, including the annual report on Form 10-K we filed with the SEC on June 26, 2025. We urge you to consider these factors, risks and uncertainties carefully in evaluating the forward-looking statements contained in this press release. All subsequent written or oral forward-looking statements attributable to our company or persons acting on our behalf are expressly qualified in their entirety by these cautionary statements. The forward-looking statements included in this press release are made only as of the date of this release. Except as expressly required by applicable securities law, we disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

 

Investor Contact:

 

Investor Contacts: IR@roadzen.ai

Media Contacts: Sanya Soni sanya@roadzen.ai or media@roadzen.ai

 

 

FAQ

What did Roadzen (RDZN) announce in this Form 8-K?

Roadzen announced a registered direct offering of 4,705,870 ordinary shares at $1.70 per share, raising gross proceeds of about $7,999,979. The deal uses its existing Form S-3 shelf registration and involves institutional investors.

How much capital is Roadzen (RDZN) raising and at what price?

Roadzen is raising approximately $7,999,979 in gross proceeds by selling 4,705,870 ordinary shares at an offering price of $1.70 per share. This equity sale is structured as a registered direct offering to institutional investors.

How will Roadzen (RDZN) use the proceeds from the share offering?

Roadzen plans to use the net proceeds primarily for working capital and general corporate purposes. The company also states it may use a portion of the funds to repay indebtedness outstanding, giving some flexibility in balance sheet management.

Who acted as placement agent in Roadzen’s registered direct offering?

Maxim Group LLC acted as the sole placement agent for Roadzen’s registered direct offering. Roadzen agreed to pay Maxim a 6.0% cash fee on aggregate gross proceeds plus $30,000 as reimbursement of accountable expenses associated with the transaction.

Under which registration statement did Roadzen (RDZN) issue these shares?

The 4,705,870 ordinary shares were issued under Roadzen’s shelf registration statement on Form S-3 (File No. 333-282966). This registration statement was declared effective by the SEC on November 12, 2024 and used with a May 4, 2026 prospectus supplement.

Does Roadzen face any restrictions on new equity issuance after this offering?

Yes. Under the placement agency agreement, Roadzen agreed for 20 days from May 5, 2026 not to issue or agree to issue most new ordinary shares or equivalents, or file certain registration statements, subject to specified exceptions like Form S-8 for employee plans.

Filing Exhibits & Attachments

10 documents